BDBM767407 2-[4-[[4-[4-[2-allyl-1-[6-(1-hydroxy- 1-methyl-ethyl)-2-pyridyl]-3-oxo- pyrazolo[3,4-d]pyrimidin-6- yl]amino]phenyl]piperazin-1- yl]methyl]phenyl]-6-fluoro-3,10- diazatricyclo[6.4.1.04,13]trideca- 1,4,6,8(13)-tetraen-9-one::US20250270212, Compound 35

SMILES C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(Cc5ccc(-c6[nH]c7cc(F)cc8c7c6CCNC8=O)cc5)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 767407   

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767407(2-[4-[[4-[4-[2-allyl-1-[6-(1-hydroxy- 1-methyl-eth...)
Affinity DataEC50:  55nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent